XML 24 R11.htm IDEA: XBRL DOCUMENT v3.24.0.1
Revenues
 12 Months Ended
Dec. 31, 2023
Revenue from Contract with Customer [Abstract]  
Revenues
Note 2. Revenues
As discussed in Note 1, revenues are recognized under guidance within ASC 606. The following table presents our disaggregated revenue for the periods presented (in thousands):
For the Years Ended,
December 31,
202320222021
JAKAFI revenues, net$2,593,732 $2,409,225 $2,134,508 
OPZELURA revenues, net337,864 128,735 4,668 
ICLUSIG revenues, net111,623 105,838 109,395 
PEMAZYRE revenues, net83,642 83,445 68,531 
MINJUVI revenues, net37,057 19,654 4,910 
ZYNYZ revenues, net1,250 — — 
Total product revenues, net3,165,168 2,746,897 2,322,012 
JAKAVI product royalty revenues367,583 331,575 337,991 
OLUMIANT product royalty revenues136,138 134,547 220,875 
TABRECTA product royalty revenues17,793 15,411 10,389 
PEMAZYRE product royalty revenues1,967 1,205 — 
Total product royalty revenues523,481 482,738 569,255 
Milestone and contract revenues7,000 165,000 95,000 
Total revenues$3,695,649 $3,394,635 $2,986,267 
For further information on our revenue-generating contracts, refer to Note 7.